Intel Falls to $86.30 as Capex Fears Outweigh a Strong Quarter — plain statement of the move plus the cause, matches recap tense
Intel closed Tuesday’s session at $86.30, down 5.86% on the day, extending a slide that has now erased most of the gains from what was, on paper, one of the stronger earnings reports the chipmaker has delivered in years. The stock has since ticked up to around $88.56 in pre-market trading Wednesday, according to CNN Markets, a reminder that this is a story about capital spending, not demand.
That’s the strange part. Intel’s Q2 2026 revenue came in at $16.1 billion, up 25% from a year earlier and well ahead of the roughly $14.4 billion Wall Street had penciled in. Adjusted earnings per share of 42 cents nearly doubled consensus estimates. Data Center and AI product revenue jumped 59%. None of that is what’s weighing on the stock right now.
The capex number that spooked the market
Intel raised its 2026 capital expenditure guidance to more than $20 billion, up from $18 billion, and told investors 2027 spending would climb further still. Management framed the increase as confidence in AI-driven demand for its chips. Investors read it differently. Free cash flow went sharply negative on an adjusted basis, and the company signaled it may need to tap capital markets to fund the buildout.
Shares initially spiked more than 12% in after-hours trading on July 23, briefly touching above $112. By the closing bell the following Friday, they had round-tripped to $92.32 — a 7.9% drop that outpaced the broader semiconductor index’s 4.5% decline that day. Tuesday’s session pushed the stock lower still, down to $86.30.
Intel Foundry remains the other pressure point. The unit generated $5.8 billion in reported segment revenue, but roughly $5.5 billion of that was internal activity eliminated in consolidation. External foundry revenue — the number that actually tests whether Intel can compete with TSMC and Samsung for outside customers — came in at just $293 million. The foundry business posted a $2.09 billion operating loss for the quarter.
Tuesday’s drop wasn’t really an Intel story in isolation. It was a chip story. The broader selloff hit memory and AI-adjacent names hard: Micron slumped 8.8%, AMD lost 8.1%, and Sandisk tumbled 14.2%, according to Trading Economics. Intel’s 5.9% decline actually landed toward the milder end of that group.
How the broader market handled it
The major indexes shrugged off the chip weakness. The S&P 500 gained 0.2% Tuesday, closing at 7,413.18. The Dow Jones Industrial Average rose 1.03%, or nearly 263 points, to 52,210.08, lifted by Coca-Cola’s earnings beat and gains in Sherwin-Williams and IBM. The Nasdaq Composite, which carries more semiconductor weight, slipped 0.18% to 24,932.08. The CBOE Volatility Index ticked up 0.48% to 18.67 — elevated, not alarmed.
| Index | Close | Change |
|---|---|---|
| S&P 500 | 7,413.18 | +0.02% (+3.68 pts) |
| Dow Jones Industrial Average | 52,210.08 | +1.03% (+262.83 pts) |
| Nasdaq Composite | 24,932.08 | -0.18% |
| VIX | 18.67 | +0.48% |
The divergence is the actual story here: a blue-chip index near records while the chip complex that powered much of 2026’s rally takes a leg down. Intel itself is a case study in that split. The stock was up roughly 163% year-to-date heading into its earnings report, and even after this pullback remains sharply higher on the year — this is a name coming off a big run, not a broken one.
What happens next
Intel’s next scheduled earnings report is October 22, 2026. Between now and then, the questions raised on the Q2 call don’t resolve themselves quickly: whether external foundry customers commit real volume to Intel’s 18A or 14A process nodes, whether the capex-to-revenue conversion investors are being asked to trust on faith actually shows up, and whether gross margin holds up against the cost inflation in memory and substrates that CFO David Zinsner has already flagged as a second-half risk.
For now, the stock trades in a wide band — Tuesday’s session alone ranged from $83.10 to $88.28 — that reflects a market still deciding whether Intel’s turnaround is being funded or overextended.